Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 1 Study of HS130 in Combination With Viagenpumatucel-L (HS110) in Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04116710
Recruitment Status : Active, not recruiting
First Posted : October 7, 2019
Last Update Posted : February 3, 2022
Information provided by (Responsible Party):
Heat Biologics

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 12, 2021
Estimated Study Completion Date : February 2022